SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

BioMarin Pharmaceutical Inc. BMRN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Analyst Price Target

BioMarin Pharmaceutical Inc. (BMRN) has 12 identified peers for comparison in the Healthcare sector. Peers include AGIO, ALNY, AMLX, APLS, ARWR, BPMC and others.

BMRN has a market capitalization of $10.67B, compared to an average peer market cap of $10.95B.

Peers & Similar Companies — BMRN

Agios Pharmaceuticals, Inc.

$33.30 +0.45% $1.95B

Alnylam Pharmaceuticals, Inc.

$339.41 +1.92% $45.01B

Amylyx Pharmaceuticals, Inc.

$16.92 +2.73% $1.41B

Apellis Pharmaceuticals, Inc.

$40.85 +0.02% $5.22B

Arrowhead Pharmaceuticals, Inc.

$66.69 +4.55% $9.34B

Blueprint Medicines Corporation

$129.46 +0.14% $8.36B

Day One Biopharmaceuticals, Inc.

$21.46 -0.14% $2.22B

$45.86 +2.00% $12.3B

Halozyme Therapeutics, Inc.

$67.31 +0.49% $7.97B

Incyte Corporation

$97.69 +2.24% $19.44B

Ionis Pharmaceuticals, Inc.

$76.76 +2.41% $12.68B

IVERIC bio, Inc.

$39.95 +0.38% $5.51B

People Also View

Alnylam Pharmaceuticals, Inc.

Incyte Corporation

Ionis Pharmaceuticals, Inc.

Karuna Therapeutics, Inc.

Arrowhead Pharmaceuticals, Inc.

Bio-Techne Corporation

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message